We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Cancer Research UK Identifies Novel Role for CD169+ Macrophages in Activating Invariant Natural Killer T Cells

Product News   Feb 09, 2011

 
Cancer Research UK Identifies Novel Role for CD169+ Macrophages in Activating Invariant Natural Killer T Cells
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

IDBS Works With SCIEX To Launch Analyst™ Software Integration

Product News

IDBS announced that it has released a fully-featured integration between the E-WorkBook electronic laboratory notebook (ELN) and SCIEX Analyst® Software, expanding IDBS’s existing family of integrations. This new integration strengthens preclinical capabilities and enables increased regulatory compliance and improved throughput.

READ MORE

UK Medtech Firm Launches App for COVID-19 Test To Help Control Pandemic

Product News

A UK medtech firm has developed a companion app for a COVID-19 test that could soon help world governments and health agencies manage and control the coronavirus pandemic.

READ MORE

PCR Biosystems Launches RiboShield™ RNase Inhibitor

Product News

PCR Biosystems has today launched RiboShield™ RNase Inhibitor. Already an important component of several PCR Biosystems kits, this robust and reliable RNase inhibitor is, for the first time, available as a standalone product.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE